Please login to the form below

Not currently logged in
Email:
Password:

MorphoSys strengthens senior clinical development team

Appoints Gabriele Elbl, Ludger Langer and Steffen Heeger

Morphosys Dr Gabriele ElblGerman biotech company MorphoSys has expanded its senior clinical development team with three new management appointments.

Regulatory affairs head Dr Gabriele Elbl (pictured right) joins MorphoSys from Munich-based biopharmaceutical company Wilex AG, where she was senior vice president of regulatory affairs.

Prior to that she worked as a scientific administrator at the EMA, London, and served as head of pharmaceutical department at Sanofi Winthrop in Munich.

Dr Ludger Langer moves to MorphoSys from contract research organisation PRA International to take up the position of head of clinical operations and project management.

He brings almost 20 years of clinical operations and project management experience to MorphoSys prior to which he was vice president, clinical operations, Europe, Asia-Pacific and Africa at PRA.

Finally MorphoSys has also appointed Dr Steffen Heeger as head of clinical research. He was previously head of medical affairs at Merck Serono, where he also led the global clinical development team for its cancer drug Erbitux.

6th January 2014

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
PRMA Consulting Ltd

PRMA Consulting is an independent consultancy solving some of the most challenging pricing, reimbursement and market access issues facing international...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics